Bruker Daltonics Introduces Advanced Solution for Quantitative Proteomics at ASMS 2005; Quantitative Proteomics for TOF/TOF and Ion Trap Mass Spectrometry in Line with HUPO PSI Standards.

SAN ANTONIO -- Bruker Daltonics Inc. today announces Proteineer-LC 1.1, a unique LC-MS/MS-based quantitative proteomics solution, and the new ProteinScape 1.3 release of its bioinformatics software. Stable Isotope Labeling Experiments (SILE) such as ICAT(TM), the more recently introduced ICPL(TM) technology, or even user-defined isotopic labels are fully supported in the new software releases. The Proteineer software suite extends the existing workflow support from 2D gel to LC-MS/MS based protein identification and quantitation using Bruker Daltonics' Ultraflex II MALDI-TOF/TOF and HCTultra ion trap mass spectrometers.

Proteineer-LC 1.1 now provides the quantitative information associated with protein identification to deliver the desired biological insights. As complex protein mixtures are analysed more and more in depth, there is a demand for proteome analyses of increasing numbers of fractions. The resulting very large amounts of data require database solutions that merge the information and provide powerful data validation tools. ProteinScape(TM) software, co-developed with Protagen AG, integrates all major search engines including Mascot(TM), Phenyx(TM) and Profound(TM). The unique MetaScore(TM) algorithm combines the results from these search engines to increase information readout. The unique ProteinExtractor(TM) algorithm generates true non-redundant protein lists from LC-MS/MS search results. Both algorithms reduce manual validation efforts significantly.

For in-depth analysis, more detailed protein sequence and modification interpretation is provided by the fully-integrated BioTools(TM) protein analysis software for interactive data validation and discovery: PTM and mutation screening, or de novo sequencing combined with homology searches allow the extraction of more information based on sequence annotated data.

LC-MALDI utilizes Bruker Daltonics' disposable Prespotted AnchorChips(TM) for highest sensitivity, elimination of interfering memory effects and ultimate spot-to-spot quantitation reproducibility. The unique Proteineer-LC 1.1 combination of LC-ESI-MALDI into a single workflow, allows scientists to validate and complement LC-ESI-MS/MS results with LC-MALDI-TOF/TOF data. The new Proteineer-LC 1.1 Survey Viewer(TM) provides a new level of interactive LC-MS and MS/MS data evaluation.

Prof. Dr. Helmut E. Meyer from the Medical Proteome Centre of the University of Bochum, Germany and Coordinator of the HUPO Brain Proteome Project (HBPP) said: "ProteinScape is already used by the HBPP research groups around the globe. We are happy to see that a great number of proteomics workflows are now manageable under ProteinScape 1.3. Within HBPP, we routinely share data from entire projects within our research network on this bioinformatics platform. This enables us to build a data collection centre providing proteomics data to the scientific community via EBI's PRIDE database."

Professor Dr. Herbert Thiele, Director of Bioinformatics at Bruker Daltonics, added: "We believe the increased functionality and algorithms of our new software suite give researchers options they have been looking for. We have collaborated with the HUPO Proteomics Standards Initiative (PSI) since its inception to define community standards for data representation in proteomics, and we fully support the mzData standard in ProteinScape 1.3."

PROTEINEER-LC 1.1 will be presented in scientific contributions from Bruker Daltonics during the 53rd ASMS conference on Mass Spectrometry in San Antonio, Texas this week.

ICAT is a trademark of the University of Washington, ICPL is a trademark of TopLab, Mascot is a trademark of Matrix Science, Phenyx is a trademark of GeneBio, Profound is a trademark of Genomics Solutions, all other trademarks are owned by Bruker Daltonics.

ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on x-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical (NBC) detection systems for homeland security. For more information: www.bruker-biosciences.com

CAUTIONARY STATEMENT OF BRUKER BIOSCIENCES

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2004, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.